# T‐bet Fate Mapping Reveals Gestational Stage‐Specific Transcriptional Adaptation of Decidual NK Cells

**Authors:** Mona A. Mohamed, Yan Li, Andrea K. Wegrzynowicz, Payton N. Lindner, Jessica Vazquez, Gladys E. Lopez, Aleksandar K. Stanic

PMC · DOI: 10.1111/aji.70220 · 2026-03-05

## TL;DR

This study shows how decidual NK cells adapt during pregnancy by changing their gene activity and cell types in response to reduced T-bet levels.

## Contribution

The study reveals a new transcriptional program in decidual NK cells driven by T-bet downregulation during gestation.

## Key findings

- T-bet-expressing NK cells progressively downregulate T-bet in decidual and placental compartments during pregnancy.
- T-bet downregulation is linked to reduced IFN-γ and cytotoxic pathways and increased tissue-residency regulators.
- Late gestation sees a shift in dNK subsets, with fewer cytotoxic cells and more regulatory and conventional NK cells.

## Abstract

Natural killer (NK) cells are critical regulators of immune balance at the maternal–fetal interface. T‐bet (Tbx21) is a key transcription factor shaping NK cell effector functions, yet its role in decidual NK (dNK) cell adaptation across gestation remains unclear.

We used a T‐bet fate‐mapping mouse model (Rosa26RFP × Tbx21Cre) to track developmental and functional reprogramming of NK cells in the uterus, decidua, and placenta throughout pregnancy. Analyses included flow cytometry, bulk RNA sequencing of fate‐mapped cells, and single‐cell transcriptomic profiling of CD45+Lineage‐ immune populations at mid and late gestation.

We found that NK cells with a history of T‐bet expression (RFP+) progressively downregulate T‐bet in a tissue and gestation‐specific manner, particularly within decidual and placental compartments. Despite this loss, RFP+ cells retained core NK cell markers and altered their lineage identity towards ILC2 or ILC3 fate. Bulk transcriptomic analysis revealed that T‐bet downregulation is associated with dampened IFN‐γ, and cytotoxic pathways and increased expression of tissue‐residency associated transcriptional regulators. Single‐cell RNAseq revealed a gestational transition in dNK subset composition, with a decline in cytotoxic tissue‐resident NK cells and expansion of regulatory and conventional NK subsets by late gestation.

These findings identify a novel transcriptional program that shapes NK cell plasticity in response to T‐bet downregulation across gestation. Rather than undergoing lineage diversion, dNK cells adapt to the decidual environment via transcriptional compensation and subset redistribution during pregnancy. This work sheds light on the temporal coordination of innate immune function relevant to pregnancy success.

## Linked entities

- **Genes:** TBX21 (T-box transcription factor 21) [NCBI Gene 30009]
- **Proteins:** TBX21 (T-box transcription factor 21), IFNG (interferon gamma)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ifngr1 (interferon gamma receptor 1) [NCBI Gene 15979] {aka CD119, IFN-gammaR, Ifgr, Ifngr, Nktar}, Gzme (granzyme E) [NCBI Gene 14942] {aka CCP3, Ctla-6, Ctla6, MCSP-2}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, TrnK (tRNA-Lys) [NCBI Gene 17734], Stat5a (signal transducer and activator of transcription 5A) [NCBI Gene 20850] {aka STAT5}, Adgre5 (adhesion G protein-coupled receptor E5) [NCBI Gene 26364] {aka Cd97, TM7LN1}, Socs1 (suppressor of cytokine signaling 1) [NCBI Gene 12703] {aka Cish1, Cish7, JAB, SOCS-1, SSI-1}, Fhl1 (four and a half LIM domains 1) [NCBI Gene 14199] {aka FHL-1, KyoT, RAM14-1, SLIM, SLIM-1}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Tcrb (T cell receptor beta chain) [NCBI Gene 21577] {aka TCRbeta, Tib}, Igfbp3 (insulin-like growth factor binding protein 3) [NCBI Gene 16009] {aka IGFBP-3, IGgfbp3}, TRIM27 (tripartite motif containing 27) [NCBI Gene 5987] {aka RFP, RNF76}, S1pr5 (sphingosine-1-phosphate receptor 5) [NCBI Gene 94226] {aka Edg8, S1P5, lpB4}, Rsad2 (radical S-adenosyl methionine domain containing 2) [NCBI Gene 58185] {aka 2510004L01Rik, SAND, Vig1, cig5}, ITGA2 (integrin subunit alpha 2) [NCBI Gene 3673] {aka BR, CD49B, FMAIT3, GPIa, HPA-5, VLA-2}, Tbx21 (T-box 21) [NCBI Gene 57765] {aka TBT1, Tbet, Tblym}, Gata3 (GATA binding protein 3) [NCBI Gene 14462] {aka Gata-3, jal}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Ccr5 (C-C motif chemokine receptor 5) [NCBI Gene 12774] {aka AM4-7, CD195, Cmkbr5}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Areg (amphiregulin) [NCBI Gene 11839] {aka AR, Mcub, Sdgf}, Cxcr6 (C-X-C motif chemokine receptor 6) [NCBI Gene 80901] {aka BONZO, STRL33}, Il15 (interleukin 15) [NCBI Gene 16168] {aka IL-15}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Prdm1 (PR domain containing 1, with ZNF domain) [NCBI Gene 12142] {aka Blimp-1, Blimp1, PRDI-BF1, ZNFPR1A1, b2b1765Clo}, Crtc2 (CREB regulated transcription coactivator 2) [NCBI Gene 74343] {aka 4632407F12Rik, Torc2}, GATA3 (GATA binding protein 3) [NCBI Gene 2625] {aka HDR, HDRS}, Itgal (integrin alpha L) [NCBI Gene 16408] {aka (p180), Cd11a, LFA-1, LFA-1A, Ly-15, Ly-21}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Gzma (granzyme A) [NCBI Gene 14938] {aka Ctla-3, Ctla3, Hf, Hf1, SE1, TSP-1}, Itga4 (integrin alpha 4) [NCBI Gene 16401] {aka CD49D, Itga4B}, Cxcr3 (C-X-C motif chemokine receptor 3) [NCBI Gene 12766] {aka Cd183, Cmkar3}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Itga2 (integrin alpha 2) [NCBI Gene 16398] {aka CD49B, DX5, GPIa}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 12767] {aka CD184, CXC-R4, CXCR-4, Cmkar4, LESTR, PB-CKR}, Lta (lymphotoxin A) [NCBI Gene 16992] {aka LT, LT-[a], LT-alpha, LT[a], LTalpha, Ltx}, Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 20846] {aka 2010005J02Rik}, Ccl3 (C-C motif chemokine ligand 3) [NCBI Gene 20302] {aka G0S19-1, LD78alpha, MIP-1alpha, MIP1-(a), MIP1-alpha, Mip1a}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, Cd55 (CD55 molecule, decay accelerating factor for complement) [NCBI Gene 13136] {aka Daf, Daf-GPI, Daf1, GPI-DAF}, Ets1 (Ets proto-oncogene 1, transcription factor) [NCBI Gene 23871] {aka D230050P06, Ets-1, Tpl1, p54, vs}, Zeb2 (zinc finger E-box binding homeobox 2) [NCBI Gene 24136] {aka 9130203F04Rik, D130016B08Rik, SIP1, Zfhx1b, Zfx1b, Zfxh1b}, Rasd2 (RASD family, member 2) [NCBI Gene 75141] {aka 4930526B11Rik, Rhes, TEM-2, TEM2}, DBA [NCBI Gene 8378], Ifngr2 (interferon gamma receptor 2) [NCBI Gene 15980] {aka Ifgr2, Ifgt}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Rorc (RAR-related orphan receptor gamma) [NCBI Gene 19885] {aka Nr1f3, RORgamma, TOR, Thor}, Bmal1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 11865] {aka Arnt3, Arntl, BMAL1b, MOP3, bHLHe5, bmal1b'}, Ccr7 (C-C motif chemokine receptor 7) [NCBI Gene 12775] {aka CC-CKR-7, CCR-7, CD197, Cdw197, Cmkbr7, EBI1}, Jak1 (Janus kinase 1) [NCBI Gene 16451] {aka BAP004, C130039L05Rik}, Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, Runx1 (runt related transcription factor 1) [NCBI Gene 12394] {aka AML1, CBF-alpha-2, Cbfa2, Pebp2a2, Pebpa2b}, Klrb1c (killer cell lectin-like receptor subfamily B member 1C) [NCBI Gene 17059] {aka CD161, Klrb1b, Ly-59, Ly55c, Ly59, NK-RP1}, Prf1 (perforin 1 (pore forming protein)) [NCBI Gene 18646] {aka Pfn, Pfp, Prf-1}, Vav1 (vav guanine nucleotide exchange factor 1) [NCBI Gene 22324] {aka Vav, vav-T}, Cd27 (CD27 antigen) [NCBI Gene 21940] {aka S152, Tnfrsf7, Tp55}, Plk3 (polo like kinase 3) [NCBI Gene 12795] {aka Cnk, Fnk, PLK-3, PRK}, Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}
- **Diseases:** gestational diabetes (MESH:D016640), NK (MESH:D000077428), SLE (MESH:D008180), impairment of vascular development (MESH:D013684), fetal growth restriction (MESH:D005317), inflammatory (MESH:D007249), preeclampsia (MESH:D011225), pregnancy failure (MESH:D051437), miscarriage (MESH:D000022), autosomal recessive microcephaly syndrome (MESH:C579935), URSA (OMIM:614389), Cytotoxicity (MESH:D064420), abortion (MESH:D000026)
- **Chemicals:** progesterone (MESH:D011374), L-chicoric acid (MESH:C100435), lipid (MESH:D008055), formaldehyde (MESH:D005557), ACK (-)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** pNK — Rattus norvegicus (Rat), Rat large granular lymphocyte leukemia, Cancer cell line (CVCL_F860), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961421/full.md

---
Source: https://tomesphere.com/paper/PMC12961421